Venture Life Group

What Venture Life Group does

Venture Life Group plc is a UK-headquartered (Bracknell) AIM-listed consumer self-care company that develops, manufactures through third-party partners, and distributes a portfolio of 8 brands and 60 products across 90+ countries. The portfolio spans four therapeutic verticals: women's intimate healthcare (vonalei, Balance Activ, Health & Her/Him, FemiClear, CUROXEN), glucose management for hypoglycaemia (Lift Glucose shots/tablets, Glucogel), ENT care (Earol® metered-dose olive oil spray, EarolSwim® water-repellent spray), and oncology support (Gelclair oral mucositis rinse, Pomi-T for PSA management, Xonrid). Revenue is split 56% from medical-device-classified products and 44% from food supplements, sold through omnichannel retail and pharmacy distribution.

The company operates an asset-light branded model following the 2025 divestiture of its lower-margin CDMO operations for €62 million. UK revenues of £25.7 million grew 20.7% in 2025, with Power Brands growing 14.9% to £33.1 million, supported by direct retailer partnerships (Boots, Superdrug, Tesco, Sainsbury's, Asda, Morrisons) and international distribution through tier-1 pharmaceutical partners (Bayer, Almirall, Viatris, Menarini, Sunstar, Phoenix, AAH). Products are clinically validated (Pomi-T double-blind RCT, Glucogel hospital use over 25 years) and protected by registered trademarks. Go-to-market combines direct retail relationships in the UK, USA, and EU with a B2B distributor model internationally and Amazon for online direct-to-consumer sales.

Financially, the business generated £35.1 million of revenue in 2025 (32% YoY growth), £6.2 million adjusted EBITDA on FY2024 continued operations, and holds £34.4 million net cash entering 2026 with an active bolt-on M&A pipeline that has already added Health & Her/Him (November 2024) and CUROXEN/FemiClear (June 2026). Capital allocation has included a £1.1 million share buyback, and ownership is dispersed among institutional investors with Slater Investments (~29.4%) and BGF Investments (~9.5%) as anchor shareholders. The company is led by CEO Jerry Randall, CFO Daniel Wells, and Executive Chairman Paul McGreevy.

Name

Venture Life Group

Legal name

Venture Life Group plc

Website

https://venture-life.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

101–250 employees

Short description

Venture Life Group plc is a UK-based, AIM-listed branded consumer self-care company developing and distributing 60 OTC products across 8 brands — spanning women's healthcare, glucose management, ENT care, and oncology support — through UK retail partners and international pharmaceutical distributors in 90+ countries.

Ownership category

akta.pro rank

Product category

Consumer Healthcare Products

NAICS

Food (Health) Supplement Retailers (456191), Pharmacies and Drug Retailers (456110), Health and Personal Care Retailers (4561)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)

akta.pro secondary industries

Vitamins & Minerals (Single Nutrients) (CRADAGAB), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Health Food & Supplement Stores (CRAHAEAC)

Keywords

• Consumer healthcare products
• Self-care medical devices
• Ear care sprays
• Hypoglycaemia glucose gels
• Women's intimate health

Headquarters

HQ city

Bracknell

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Power Brands Portfolio Sales: Revenue from branded consumer healthcare products including Balance Activ, Lift/Glucogel, Earol, and Health & Her/Him. Power Brands portfolio grew 14.9% to £33.1 million in 2025.
2. OTC Healthcare Products: 56% revenue from medical devices, 44% from supplements. Products distributed through retail and pharmacy channels globally.
3. International Distribution: B2B international business model through distribution partners in markets outside UK, USA and EU. Partners cover local marketing and distribution costs.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Venture Life Group develops, manufactures and distributes branded, non-prescription consumer self-care products across four therapeutic areas: Women's Healthcare (vonalei), Glucose Management (Lift Glucose shots/tablets and Glucogel 40% dextrose gel), ENT Care (Earol and EarolSwim metered-dose olive oil sprays) and Oncology Support (Gelclair oral rinse and Pomi-T food supplement). The portfolio comprises 8 brands and 60 products, with 56% of revenue from medical devices and 44% from food supplements, sold through pharmacies, grocery retailers, and international distributors in over 90 countries.

Product overview

Venture Life Group is a pure branded consumer healthcare business that develops and distributes non-drug, prescription-free products for the global self-care market. The company operates across 8 brands and 60 products, with 56% of revenue from medical devices and 44% from supplements. The product portfolio spans four key therapeutic areas: Women's Healthcare (vonalei for bacterial vaginosis, vaginal atrophy, candidiasis), Glucose Management (Lift Glucose products and Glucogel for hypoglycaemia), ENT Care (Earol® and EarolSwim® for ear wax removal and swimmer's ear protection), and Oncology Support (Pomi-T, Gelclair, and Xonrid for cancer treatment side effects). The company sells through omnichannel distribution in key markets (UK, USA, EU) via retailers and distributors, with products available in over 90 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• vonalei: Women's healthcare products including treatments for Bacterial Vaginosis, Vaginal Atrophy, Candidiasis, and Intimate Cleansing Foam.
• Lift Glucose
• Glucogel
• Earol
• EarolSwim
• Pomi-T
• Gelclair
• Xonrid
• Balance Activ
• Health & Her/Him

Products and services

• vonalei

Quantifiable outcome

• Revenue of £35.1 million in 2025, representing 32% year-on-year increase
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

17 partnerships are on record, tiered core.

• AlliancecoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical/healthcare distribution partner for Venture Life products in certain markets.
• BayercoreChannel Partner/ Reseller/ DistributorPharmaceutical partner distributing Venture Life products internationally through healthcare channels.
• AlmirallcoreChannel Partner/ Reseller/ DistributorPharmaceutical partner for international distribution of self-care products.
• SunstarcoreChannel Partner/ Reseller/ DistributorHealthcare distribution partner for Venture Life product portfolio.
• MenarinicoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical distributor for consumer healthcare products.
• ViatriscoreChannel Partner/ Reseller/ DistributorGlobal healthcare partner distributing Venture Life products internationally.
• BootscoreChannel Partner/ Reseller/ DistributorUK pharmacy retail partner with direct distribution relationship. Venture Life invests in advertising and promotion.
• SuperdrugcoreChannel Partner/ Reseller/ DistributorUK pharmacy retail partner for consumer healthcare products.
• TescocoreChannel Partner/ Reseller/ DistributorUK grocery retail partner for product distribution through supermarket channels.
• Sainsbury'scoreChannel Partner/ Reseller/ DistributorUK grocery retail partner for product availability in supermarkets.
• AsdacoreChannel Partner/ Reseller/ DistributorUK grocery retail partner for product distribution.
• MorrisonscoreChannel Partner/ Reseller/ DistributorUK grocery retail partner for product availability.
• AmazoncoreChannel Partner/ Reseller/ DistributorE-commerce platform partner for online product sales globally.
• PhoenixcoreChannel Partner/ Reseller/ DistributorEuropean pharmaceutical wholesaler and distributor partner.
• FarmaciacoreChannel Partner/ Reseller/ DistributorPharmacy distribution partner for European markets.
• CoopercoreChannel Partner/ Reseller/ DistributorHealthcare product distributor partner.
• AAHcoreChannel Partner/ Reseller/ DistributorUK pharmaceutical wholesaler and distributor.

Scale indicators10 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Church & Dwight: US-listed CPG company with consumer healthcare brands (Batiste, First Response, Trojan). Comparable as a multi-brand consumer healthcare company with retail and pharmacy distribution, though much larger.
• Haleon: Global consumer healthcare leader (formerly GSK Consumer Healthcare) with brands like Sensodyne, Centrum, and Voltaren. Comparable as a broad incumbent in consumer self-care and OTC medical devices/supplements, though much larger scale than Venture Life.
• Bayer Consumer Health: Pharmaceutical company's consumer health division with brands like Claritin, Aspirin, and Bepanthen. Comparable in offering OTC self-care brands globally; already a distribution partner for Venture Life products.
• Perrigo Company: Large OTC consumer healthcare and self-care products manufacturer. Comparable in offering consumer self-care brands across multiple therapeutic categories and operating in the pharmacy/retail channel globally.
• Mylan (now Viatris) Consumer Healthcare: Global healthcare company offering OTC consumer healthcare products. Comparable as a broad incumbent with self-care brands; existing distribution partner for Venture Life.
• Sanofi Consumer Healthcare: Global pharmaceutical company with significant consumer healthcare (CHC) segment including brands like Doliprane and Mucosolvan. Comparable in offering OTC self-care products across multiple categories globally.

Direct peers

• Omega Pharma (now Perrigo): European OTC healthcare company with portfolio of self-care brands. Direct comparable as a mid-sized European consumer healthcare company focused on pharmacy channels.
• Prestige Consumer Healthcare: US-based OTC consumer healthcare company with a portfolio of branded self-care products across multiple therapeutic areas. Closely comparable business model as a focused branded consumer healthcare rollup in similar size category.
• Recordati Industria Chimica: European specialty pharmaceutical company with consumer healthcare focus, particularly in women's health and self-care OTC products. Comparable in size and therapeutic verticals (women's health, specialty self-care).

Regional players

• Diurnal Group: UK-based specialty pharmaceutical company focused on endocrine and rare disease treatments. Comparable as a small UK-listed healthcare company focused on specialty therapeutic areas with similar size and listing structure (AIM).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/venture-life

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Venture Life Group